Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania
about
Effects of Invariant NKT Cells on Parasite Infections and Hygiene HypothesisCytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasisClinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigenAlpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasisLipid and glycolipid antigens of CD1d-restricted natural killer T cells.TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trialsImmune modulating effects of NKT cells in a physiologically low dose Leishmania major infection model after αGalCer analog PBS57 stimulationIncorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity.Intradermal naked plasmid DNA immunization: mechanisms of action.Regulation of NKT Cell Localization in Homeostasis and InfectionHookworm excretory/secretory products modulate immune responses to heterologous and species-specific antigens.Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.
P2860
Q26738653-87AA5CBC-0AEB-4069-A7EA-DBD5A0D6157BQ28485121-B8988BE4-E03E-4683-A984-667315AAA2EDQ28539852-C10CACCC-54AC-405E-89B4-AE357404D5FDQ30377447-D26C8ED6-17BA-4D4D-A9FC-6DB88EECD795Q33559668-A13F157D-3B1A-458D-A5D2-9A7020926E1CQ33724575-3C3FA552-EA70-4FE7-ADF9-C2305E0D93C4Q33939303-3CDA6769-16E6-484B-8B87-ECB8E0E80DCDQ34671806-084A5B33-B9D1-450A-962C-654EC770FEF5Q35195426-17BB6876-2EBA-4C02-8C1D-2AFEDB4AAB98Q37286356-3B81FEB0-5B71-4726-A0F6-E35C9A103579Q37644961-5BBB7789-8CA1-4263-B88E-FC0908144AC2Q37919894-38499CBE-1AFD-4040-AA8E-7692110D50A7Q38527820-0547ABF7-CB32-43A2-A1F8-5B2BD262CC28Q38630359-11A57E87-51DA-44A4-9A61-6511EAB9F309Q44218777-15CD69C1-3EB4-460B-95A7-F8C101B25B4FQ51875279-DC514F97-0155-4F43-9B7C-9DDBFE3E2AB6
P2860
Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Intradermal NKT cell activatio ...... protection against Leishmania
@ast
Intradermal NKT cell activatio ...... protection against Leishmania
@en
type
label
Intradermal NKT cell activatio ...... protection against Leishmania
@ast
Intradermal NKT cell activatio ...... protection against Leishmania
@en
prefLabel
Intradermal NKT cell activatio ...... protection against Leishmania
@ast
Intradermal NKT cell activatio ...... protection against Leishmania
@en
P2093
P2860
P356
P1476
Intradermal NKT cell activatio ...... protection against Leishmania
@en
P2093
Blaise Dondji
Diane McMahon-Pratt
Eszter Deak
Karen Goldsmith-Pestana
Mariano Esteban
Sachiko Miyake
Takashi Yamamura
P2860
P304
P356
10.1002/EJI.200737660
P407
P577
2008-03-01T00:00:00Z